Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Angela Genge

Showing results (21-30 of 111) with videos related to

Pageof 12
Sort By:
Computerized Medical Imaging and Graphics : the Official Journal of the Computerized Medical Imaging Society|December 2, 2019
Texture classification of MR images of the brain in ALS using M-CoHOG: A multi-center studyG M Mashrur E Elahi, Sanjay Kalra, Lorne Zinman, et al.
International Journal of Speech-Language Pathology|June 5, 2023
Speech timing and monosyllabic diadochokinesis measures in the assessment of amyotrophic lateral sclerosis in Canadian FrenchLiziane Bouvier, Scotia McKinlay, Justin Truong, et al.
European Journal of Neurology|May 20, 2023
Diagnostic delay in amyotrophic lateral sclerosisKelly G Gwathmey, Philippe Corcia, Chris J McDermott, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|January 27, 2026
The genetics of autosomal recessive ALS: a review of the common forms and their phenotypesMatti D Allen, Vanessa Diab, Nastasija Lezaic, et al.
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|October 27, 2025
Cost-Effectiveness Analysis of Efgartigimod vs Chronic Immunoglobulin for the Treatment of Myasthenia Gravis in CanadaZaeem A Siddiqi, Cynthia Z Qi, Allen Zhou, et al.
European Journal of Human Genetics : EJHG|July 6, 2026
A changed landscape: five-year retrospective on the paradigm shift in genetic testing practices for ALS in CanadaMaya Binet, Gordon Jewett, Ari Breiner, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|November 1, 2018
Relationships between slow vital capacity and measures of respiratory function on the ALSFRS-RCarlayne Jackson, Mamede De Carvalho, Angela Genge, et al.
Muscle & Nerve|July 1, 2025
Analysis of Long-Term Function and Survival of Edaravone Oral Suspension-Treated Patients With Amyotrophic Lateral Sclerosis Using PRO-ACT Data as Historical Placebo ControlsFumihiro Takahashi, Angela Genge, Manabu Hirai, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|May 20, 2026
Types and frequencies of adverse events across clinical trials for patients with amyotrophic lateral sclerosis: an analysis of the Pooled Resource Open-Access ALS Clinical Trials (PRO-ACT) databaseSangmi Kim, Sarah E Curtis, Diego Iacono, et al.
Neurology|April 21, 2026
Heterogeneity in the Analysis of the ALSFRS-R in ALS Clinical Trials and its Effect on the Validity and Precision of Trial ConclusionsDaphne N Weemering, Jordi W J van Unnik, Angela Genge, et al.
Pageof 12

Showing results (21-30 of 111) with videos related to

Sort By:
Pageof 12
Computerized Medical Imaging and Graphics : the Official Journal of the Computerized Medical Imaging Society|December 2, 2019
Texture classification of MR images of the brain in ALS using M-CoHOG: A multi-center studyG M Mashrur E Elahi, Sanjay Kalra, Lorne Zinman, et al.
International Journal of Speech-Language Pathology|June 5, 2023
Speech timing and monosyllabic diadochokinesis measures in the assessment of amyotrophic lateral sclerosis in Canadian FrenchLiziane Bouvier, Scotia McKinlay, Justin Truong, et al.
European Journal of Neurology|May 20, 2023
Diagnostic delay in amyotrophic lateral sclerosisKelly G Gwathmey, Philippe Corcia, Chris J McDermott, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|January 27, 2026
The genetics of autosomal recessive ALS: a review of the common forms and their phenotypesMatti D Allen, Vanessa Diab, Nastasija Lezaic, et al.
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|October 27, 2025
Cost-Effectiveness Analysis of Efgartigimod vs Chronic Immunoglobulin for the Treatment of Myasthenia Gravis in CanadaZaeem A Siddiqi, Cynthia Z Qi, Allen Zhou, et al.
European Journal of Human Genetics : EJHG|July 6, 2026
A changed landscape: five-year retrospective on the paradigm shift in genetic testing practices for ALS in CanadaMaya Binet, Gordon Jewett, Ari Breiner, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|November 1, 2018
Relationships between slow vital capacity and measures of respiratory function on the ALSFRS-RCarlayne Jackson, Mamede De Carvalho, Angela Genge, et al.
Muscle & Nerve|July 1, 2025
Analysis of Long-Term Function and Survival of Edaravone Oral Suspension-Treated Patients With Amyotrophic Lateral Sclerosis Using PRO-ACT Data as Historical Placebo ControlsFumihiro Takahashi, Angela Genge, Manabu Hirai, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|May 20, 2026
Types and frequencies of adverse events across clinical trials for patients with amyotrophic lateral sclerosis: an analysis of the Pooled Resource Open-Access ALS Clinical Trials (PRO-ACT) databaseSangmi Kim, Sarah E Curtis, Diego Iacono, et al.
Neurology|April 21, 2026
Heterogeneity in the Analysis of the ALSFRS-R in ALS Clinical Trials and its Effect on the Validity and Precision of Trial ConclusionsDaphne N Weemering, Jordi W J van Unnik, Angela Genge, et al.
Pageof 12